# 1. Financial Performance ## A. Key Figures * **Consolidated Revenue:** **₹1,922 Cr** Q2 FY26 (+QoQ) · **₹3,836 Cr** H1 FY26 (-9.5% YoY) * **EBITDA:** **₹224 Cr** Q2 FY26 (+5% QoQ, 12% margin) · **₹438 Cr** H1 FY26 (11% margin) * **PBT & PAT:** **₹163 Cr** PBT Q2 FY26 (+5%) · **₹119 Cr** PAT Q2 FY26 (+6%) * **ROCE:** **14%** (Q2 FY26) * **Debt-to-Equity Ratio:** **21** · **Net Worth:** **₹5,550 Cr** ## B. Revenue & Profit * **Sequential Recovery:** Revenue and profitability improved **quarter-on-quarter**, signaling stabilization after a weak first half, with margin expansion driven by operational efficiencies. * **Annual Decline Context:** Full-year-to-date performance reflects **significant YoY revenue and EBITDA contraction**, primarily due to challenging market conditions and lower realization. * **Profit Conversion:** Strong bottom-line growth **outpacing EBITDA**, indicating effective tax management or other non-operating gains. ## C. Margins & ROCE * **Market Share Gains:** Resilient performance amid headwinds, supported by **expanded share in the Phenolics segment** and disciplined capital allocation. * **Cost Discipline:** Ongoing **cost-cutting initiatives** have reduced fixed costs in H1 and are expected to deliver **further savings** in H2. * **Feedstock Clarity Pending:** Management refrained from providing propylene cost sensitivity, citing **distorted index pricing**, with updated guidance expected by Q1 FY27. ## D. Balance Sheet * **Robust Financial Position:** High net worth and **minimal leverage** (debt/equity of 21) provide strong capacity for funded growth. * **Capital Allocation Clarity:** **95% of ~₹2,000 Cr investments** is allocated outside phenol and polycarbonate projects, reducing exposure concerns in those segments. --- # 2. Segment Performance ## A. Key Figures * **Phenolics Revenue:** ₹1,333 Cr Q2 (+2% QoQ) · ₹2,637 Cr H1 * **Phenolics EBIT:** ₹145 Cr Q2 (+23% QoQ) · ₹263 Cr H1 (10% margin) * **Advanced Intermediates Revenue:** ₹588 Cr Q2 (-3% YoY) · ₹1,193 Cr H1 * **Advanced Intermediates EBIT:** ₹23 Cr Q2 · ₹58 Cr H1 (5% margin) ## B. Phenolics Business * **Strong Profitability Growth:** EBIT surged **23% sequentially** on record IPA output, favorable mix, and lower feedstock costs despite modest revenue growth. * **Volume Constraints Offset by Operational Gains:** Q2 phenol volumes rose only **2–3% YoY** due to adverse weather in Dahej, yet efficiency improvements sustained margin expansion. * **Strategic Expansion Pipeline:** Upstream (Nitric Acid) and downstream (MIBK, MIBC) product rollouts underway, with early market seeding via group facilities. * **Market Share Benefit from Trade Curtailment:** AI segment headwinds provide short-term advantage, allowing Phenolics to retain share and command **small pricing premiums**. ## C. Advanced Intermediates * **Revenue & Profit Pressure in Q2:** Segment faced **3% YoY revenue decline** due to missing high-value product sales, with volume gains offset by unfavorable product mix. * **Cost Optimization Underway:** Aggressive measures implemented to restore profitability, with benefits expected in coming quarters. * **Preoperative Costs Weighed on Margins:** **₹15 Cr** in preoperative expenses repeated in Q2, suppressing EBIT despite operational adjustments. * **Enhanced Asset Flexibility:** Repurposed production lines over past **six months** now support multiple agrochemical and life science intermediates, improving resilience. --- # 3. Capacity & Commissioning ## A. Key Figures * **Investment Timeline:** ₹2,000 Cr fully capitalized by **June 2026** * **Storage Capacity:** **~15x increase** vs. prior, from **1-day to ~15 days of consumption** * **Nitric Acid Capacity:** **250–270 TPD** nameplate; WNA slightly lower * **Hydrogenation Commissioning:** **INR 118 Cr** asset live as of **26 Sep 2025** ## B. Project Timeline * **Flagship Polycarbonate Complex:** Ground broken for India’s first integrated polycarbonate mega complex, targeting **integrated phenolics value chain** and **resin production by March 2028**, with site dismantling underway in Germany. * **Execution Momentum:** EPCM appointed and contractor approved; **no critical path dependencies**, with BPA technology under review but **not blocking progress**. * **CAPEX Strategy:** Prioritizing retrofit of proven asset over greenfield build, avoiding **~100% higher material costs** for exotic alloys. * **Near-Term Commissioning:** Nitration and nitric acid units to start this quarter; multi-purpose and MIBK/MIBC plants by **March 2026**, with full project completion by **Q1 FY26**. * **Supply Resilience:** Ammonia secured via **dual sourcing (import + domestic)** and indexed pricing; **expanded storage** mitigates historical logistics risk. ## C. Ramp-up Progress * **Rapid Upstream Ramp-up:** Nitric acid, nitration, and hydrogenation assets expected to scale quickly due to **assured captive demand** and **flexible, multi-product configurations**. * **Multi-Purpose Plant Delay:** Initial ramp-up to take **3–5 months** post-commissioning due to **customer validation**, with high utilization expected from **mid-Q3 FY26 onward**. * **Debottlenecking Sustains Growth:** **Ongoing efficiency gains** of ~4% per quarter achieved with minimal CAPEX, building on prior **10% capacity expansion**. * **Volatility Mitigation:** New **multi-product, stream-based approach** enhances resilience across Chem Tech operations, supporting a **chemistry-focused, product-agnostic model**. * **Integration Confidence:** Improved coordination between Deepak Nitrite and Phenolics teams has resolved prior delays, boosting confidence in **commissioning execution**. --- # 4. Product & R&D ## A. Key Figures * **R&D Center Investment:** **INR 100 Cr** on 5-acre Savli campus * **New Products Launched:** **7** homegrown products initiated in Q2 * **Technology Agreements:** **Phenol plant licensing** secured · **Polycarbonate resin tech** agreement with Trinseo finalized ## B. New Product Launch * **Innovation Momentum:** Seven new in-house products launched with **strong margin profiles** and high volume-profit upside, targeting life sciences and performance chemicals. * **Global Market Access:** Products aimed at **Japan and EU** markets facing 3–5 month validation cycles; early feedback shows specs exceed current standards. * **Capital-Efficient Scaling:** Production to leverage existing/refurbished assets with **no major capex**, limited to minor upgrades in solid handling and HVAC systems. * **Agrochemical Commercialization:** Market entry imminent this quarter via strategic partnerships, enabling rapid scale without new infrastructure. ## C. R&D Capabilities * **Integrated Innovation Engine:** Savli R&D center enables end-to-end product development—from idea to scale-up—supporting **multi-product campaigns** and faster asset turnover. * **Strategic Differentiation:** Three-pronged R&D strategy focuses on **new molecule development, process intensification**, and **reactor repurposing**, enhancing operational agility. * **Digital & Collaborative Edge:** Use of **AI, data lakes, and modeling tools** allows rapid internal tech pack creation, strengthening CDMO/CMO positioning and global partner appeal. * **Long-Term Platform Scale:** Aims to host **India’s largest number of chemistry platforms under one roof** by next fiscal year, driven by in-house R&D and digital capital. --- # 5. Demand & Export Mix ## A. Key Figures * **Domestic Revenue:** **₹1,632 Cr** Q2 · **₹3,256 Cr** H1 * **Export Revenue:** **₹270 Cr** Q2 · **₹536 Cr** H1 * **Domestic:Export Mix:** **86:14** (consolidated) ## B. Domestic vs Export * **Dominant Domestic Exposure:** Overwhelming revenue contribution from domestic operations, reflecting structural reliance on India’s growing industrial demand. * **Sunrise Sector Tailwinds:** Strong domestic demand momentum in EVs, electronics, and healthcare underpins polycarbonate growth, with India positioned to leverage **second-mover advantage** from China’s mature market experience. ## C. Agrochemical Recovery * **Near-Zero Intermediates Demand in Q2:** Extended inventory destocking cycle across global agrochemical majors suppressed volumes to negligible levels for four to five quarters. * **H2 Recovery Expected:** Cautious resumption of material movement anticipated imminently, with improving customer engagement across **India and China**, though final ramp-up depends on U.S. tariff outcomes and crop market dynamics. * **Quality Validation Ahead of Volume Scale:** Product performance has **exceeded expectations**, but commercial ramp remains pending formal customer approvals. --- # 6. Risks & Trade Factors ## A. Key Figures * **Energy Sourcing Target:** **60% renewable**, potentially rising to **over 70%** * **Emission & Efficiency:** **Reduced emission score** and **improved energy intensity** in H1 FY26 ## B. U.S. Tariffs * **Pricing Pressure:** Advanced Intermediates segment faced **severe realization and profitability pressure** from U.S. tariffs and underpriced imports, despite stable revenues via diversification. * **Demand Disruption:** Global uncertainty from tariffs impacted agrochemical intermediate demand, with **prolonged inventory buildup**—especially in Q2—suppressing production and sales. * **Feedstock Resilience:** Russian oil sanctions unlikely to **dramatically impact** key aromatics pricing in India due to diversified trade flows from Korea, Thailand, and South Asia. ## C. Chinese Dumping * **Market Defense:** Company maintained **high production efficiencies and throughput** to defend market and wallet share despite dumping, prioritizing plant optimization and compliance over sanction-risk arbitrage. * **Strategic Trade-off:** Ongoing challenge in balancing **wallet share retention** against **price premium erosion**, particularly in dumped products like sodium nitrite, DASDA, and nitro aromatics. * **Market Distortion:** Phenol spread depression driven not by fundamentals but by --- # 7. Guidance & Outlook ## A. H2 Expectations * **Cautious Optimism for H2:** Management expects improvement in H2 over Q2, driven by better market sentiment and commissioning of strategic investments at Deepak Chem Tech. * **Seasonal & Operational Tailwinds:** Higher output anticipated in H2 due to cooler winter conditions and ongoing plant efficiency gains, with further optimization headroom identified. * **Transformation Underway:** Company entering a transformative growth phase, underpinned by upstream integration, digital transformation, and renewable energy initiatives to drive sustainable, innovation-led growth. * **Key Catalysts Ahead:** Full financial impact from integration projects expected from December 2025 onward, with peak contributions achieved by year-end; AI segment to benefit from debottlenecked capacities and stronger value chain contribution. * **Upside Optionality:** A favorable resolution of the U.S. tariff issue could trigger an upward revision to performance expectations. ## B. FY27 Impact * **Material FY27 Contribution Expected:** New agrochemical products set to ramp up aggressively by end-FY26/mid-Q1 FY27, with significant financial impact anticipated in **Q2 FY27**. * **Sustainable Value Framework:** Strategic focus on disciplined execution, prudent capital allocation, and long-term competitiveness to deliver enduring stakeholder value.